Looking back to the embryo: Defining transcriptional networks in adult myogenesis

Nature Reviews Genetics

Volumn 4, Issue 7, 2003, Pages 497-507

  Parker, Maura H ^a,b   Seale, Patrick ^a,b   Rudnicki, Michael A ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MYOCYTE ENHANCER FACTOR 2; MYOGENIC FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR PAX7; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; CELL DIFFERENTIATION; EMBRYO; EMBRYO DEVELOPMENT; GENETIC TRANSCRIPTION; MOUSE; MUSCLE DEVELOPMENT; MUSCLE HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SKELETAL MUSCLE; STEM CELL; TRANSCRIPTION REGULATION;

ADULT; ANIMALS; CELL DIFFERENTIATION; EMBRYO; HUMANS; MICE; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; REGENERATION; STEM CELLS; TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 0038480134     PISSN: 14710056     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrg1109     Document Type: Review

References (133)

1. Ferrari, G. et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279, 1528-1530 (1998). This seminal study documents the capacity for transplanted bone-marrow cells from transgenic mice to migrate to sites of muscle degeneration and differentiate into muscle. This report proposes the possibility that bone-marrow cells might be used as a source of myogenic progenitors to treat muscle disease.
2. La Barge, M. A. & Blau, H. M. Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell 111, 589-601 (2002). This important work shows that transplanted bone-marrow cells can give rise to satellite cells after exercise-induced regeneration. This indicates that marrow-derived differentiation into non-hematopoeitic tissues might be mediated through a tissue-specific stem-cell intermediate, such as the muscle satellite cell.
3. Summerbell, D. & Rigby, P. W. Transcriptional regulation during somitogenesis. Curr. Top. Dev. Biol. 48, 301-318 (2000).
4. Pourquie, O. Vertebrate somitogenesis. Annu. Rev. Cell. Dev. Biol. 17, 311-350 (2001).
5. Pownall, M. E., Gustafsson, M. K. & Emerson, C. P. Myogenic regulatory factors and the specification of muscle progenitors in vertebrate embryos. Annu. Rev. Cell. Dev. Biol. 18. 747-783 (2002).
6. Brent, A. E., Schweitzer, R. & Tabin, C. J. A somitic compartment of tendon progenitors. Cell 113, 235-248 (2003).
7. Jostes, B., Walther, C. & Gruss, P. The murine paired box gene. Pax7, is expressed specifically during the development of the nervous and muscular system. Mech. Dev. 33, 27-37 (1990).
8. Goulding, M., Lumsden, A. & Paquette, A. J. Regulation of Pax-3 expression in the dermomyotome and its role in muscle development. Development 120, 957-971 (1994).
9. Kiefer, J. C. & Hauschka, S. D. Myf-5 is transiently expressed in nonmuscle mesoderm and exhibits dynamic regional changes within the presegmented mesoderm and somites I-IV. Dev. Biol. 232, 77-90 (2001).
10. Hirsinger, E. et al. Notch signalling acts in postmitotic avian myogenic cells to control MyoD activation. Development 128, 107-116 (2001).
11. Amthor, H., Christ, B. & Patel, K. A molecular mechanism enabling continuous embryonic muscle growth - a balance between proliferation and differentiation. Development 126, 1041-1053 (1999). This paper proposes the hypothesis that embryonic myogenesis requires a temporal balance between proliferation and differentiation that is achieved through the presence of external cues, such as BMP and Shh signalling, and regulation of the expression of Pax3 and MyoD.
12. Christ, B. & Ordahl, C. P. Early stages of chick somite development. Anat. Embryol. 191, 381-396 (1995).
13. Ordahl, C. P. & Le Douarin, N. M. Two myogenic lineages within the developing somite. Development 114, 339-353 (1992).
14. Puri, P. L. & Sartorelli, V. Regulation of muscle regulatory factors by DNA-binding, interacting proteins, and posttranscriptional modifications. J. Cell. Physiol. 185, 155-173 (2000).
15. Perry, R. L. & Rudnick, M. A. Molecular mechanisms regulating myogenic determination and differentiation. Front. Biosci. 5, D750-D767 (2000).
16. Bergstrom, D. A. & Tapscott, S. J. Molecular distinction between specification and differentiation in the myogenic basic helix-loop-helix transcription factor family. Mol. Cell. Biol. 21, 2404-2412 (2001).
17. Naya, F. J., Wu, C., Richardson, J. A., Overbeek, P. & Olson, E. N. Transcriptional activity of MEF2 during mouse embryogenesis monitored with a MEF2-dependent transgene. Development 126, 2045-2052 (1999).
18. Naya, F. S. & Olson, E. MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation. Curr. Opin. Cell. Biol. 11, 683-688 (1999).
19. Naidu, P. S., Ludolph, D. C., To, R. Q., Hinterberger, T. J. & Konieczny, S. F. Myogenin and MEF2 function synergistically to activate the MRF4 promoter during myogenesis. Mol. Cell. Biol. 15, 2707-2718 (1995).
20. Ridgeway, A. G., Wilton, S. & Skerjanc, I. S. Myocyte enhancer factor 2C and myogenin up-regulate each other's expression and induce the development of skeletal muscle in P19 cells. J. Biol. Chem. 275, 41-46 (2000).
21. Novitch, B. G., Mulligan, G. J., Jacks, T. & Lassar, A. B. Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle. J. Cell. Biol. 135, 441-456 (1996).
22. Novitch, B. G., Spicer, D. B., Kim, P. S., Cheung, W. L. & Lassar, A. B. pRb is required for MEF2-dependent gene expression as well as cell-cycle arrest during skeletal muscle differentiation. Curr. Biol. 9. 449-459 (1999).
23. Lin, J. et al. Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres. Nature 418, 797-801 (2002).
24. Kablar, B. et al. Myogenic determination occurs independently in somites and limb buds. Dev. Biol. 206, 219-231 (1999).
25. Tajbakhsh, S., Rocancourt, D. & Buckingham, M. Muscle progenitor cells failing to respond to positional cues adopt non-myogenic fates in myf-5 null mice. Nature 384, 266-270 (1996).
26. Kablar, B. et al. MyoD and Myf-5 differentially regulate the development of limb versus trunk skeletal muscle. Development 124, 4729-4738 (1997).
27. Ordahl, C. P. & Williams, B. A. Knowing chops from chuck: roasting myoD redundancy. Bioessays 20, 357-362 (1998).
28. Hasty, P. et al. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature 364, 501-506 (1993).
29. Nabeshima, Y. et al. Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature 364, 532-535 (1993).
30. Braun, T. & Arnold, H. H. Inactivation of Myf-6 and Myf-5 genes in mice leads to alterations in skeletal muscle development. EMBO J. 14, 1176-1186 (1995).
31. Patapoutian, A. et al. Disruption of the mouse MRF4 gene identifies multiple waves of myogenesis in the myotome. Development 121, 3347-3358 (1995).
32. Zhang, W., Behringer, R. R. & Olson, E. N. Inactivation of the myogenic bHLH gene MRF4 results in up-regulation of myogenin and rib anomalies. Genes Dev. 9, 1388-1399 (1995).
33. Tajbakhsh, S. et al. Gene targeting the myf-5 locus with nlacZ reveals expression of this myogenic factor in mature skeletal muscle fibres as well as early embryonic muscle. Dev. Dyn. 206, 291-300 (1996).
34. Carvajal, J. J., Cox, D., Summerbell, D. & Rigby, P. W. A BAC transgenic analysis of the Mrf4/Myf5 locus reveals interdigitated elements that control activation and maintenance of gene expression during muscle development. Development 128, 1857-1868 (2001).
35. Hadchouel, J. et al. Modular long-range regulation of Myf5 reveals unexpected heterogeneity between skeletal muscles in the mouse embryo. Development 127, 4455-4467 (2000).
36. Summerbell, D. et al. The expression of Myf5 in the developing mouse embryo is controlled by discrete and dispersed enhancers specific for particular populations of sketetal muscle precursors. Development 121, 3745-3757 (2000).
37. Sporle, R., Gunther, T., Struwe, M. & Schughart, K. Severe defects in the formation of epaxial musculature in open brain (opb) mutant mouse embryos. Development 122, 79-86 (1996).
38. Dietrich, S., Schubert, F. R., Gruss, P. & Lumsden, A. The role of the notochord for epaxial myotome formation in the mouse. Cell. Mol. Biol. 45, 601-616 (1999).
39. Asakura, A. & Tapscott, S. J. Apoptosis of epaxial myotome in Danforth's short-tail (Sd) mice in somites that form following notochord degeneration. Dev. Biol. 203, 276-289 (1998).
40. Borycki, A. G. et al. Sonic hedgehog controls epaxial muscle determination through Myf5 activation. Development 126, 4053-4063 (1999).
41. Gustafsson, M. K. et al. Myf5 is a direct target of long-range Shh signaling and Gli regulation for muscle specification. Genes Dev. 16, 114-126 (2002). This study is the first to provide a direct association between environmental cues that regulate myogenesis and the activation of a muscle-specification gene. Specifically, the authors show that long-range Shh signalling activates Myf5 through Gti1 binding sites in the Myf5 epaxial somite enhancer.
42. Chiang, C. et al. Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. Nature 383, 407-413 (1996).
43. Kruger, M. et al. Sonic hedgehog is a survival factor for hypaxial muscles during mouse development. Development 128, 743-752 (2001).
44. Duprez, D., Fournier-Thibault, C. & Le Douarin, N. Sonic Hedgehog induces proliferation of committed skeletal muscle cells in the chick limb. Development 125, 495-505 (1998).
45. Pourquie, O., Coltey, M., Breant, C. & Le Douarin, N. M. Control of somite patterning by signals from the lateral plate. Proc. Natl Acad. Sci. USA 92, 3219-3223 (1995).
46. Pourquie, O. et al. Lateral and axial signals involved in avian somite patterning: a role for BMP4. Cell 84, 461-471 (1996).
47. Cossu, G. et al. Activation of different myogenic pathways: myf-5 is induced by the neural tube and MyoD by the dorsal ectoderm in mouse paraxial mesoderm. Development 122, 429-437 (1996).
48. Tajbakhsh, S. et al. Differential activation of Myf5 and MyoD by different Wnts in explants of mouse paraxiaf mesoderm and the later activation of myogenesis in the absence of Myf5. Development 125, 4155-4162 (1998).
49. Borello, U. et al. Transplacental delivery of the Wnt antagonist Frzb1 inhibits development of caudal paraxial mesoderm and skeletal myogenesis in mouse embryos. Development 126, 4247-4255 (1999).
50. Amthor, H., Christ, B., Weil, M. & Patel, K. The importance of timing differentiation during limb muscle development. Curr. Biol. 8, 642-652 (1998).
51. Dietrich, S., Schubert, F. R., Healy, C., Sharpe, P. T. & Lumsden, A. Specification of the hypaxial musculature. Development 125, 2235-2249 (1998).
52. Hirsinger, E. et al. Noggin acts downstream of Wnt and Sonic Hedgehog to antagonize BMP4 in avian somite patterning. Development 124, 4605-4614 (1997).
53. Reshef, R., Maroto, M. & Lassar, A. B. Regulation of dorsal somitic cell fates: BMPs and Noggin control the timing and pattern of myogenic regulator expression. Genes Dev. 12, 290-303 (1998).
54. McMahon, J. A. et al. Noggin-mediated antagonism of BMP signaling is required for growth and patterning of the neural tube and somite. Genes Dev. 12, 1438-1452 (1998).
55. Delfini, M., Hirsinger, E., Pourquie, O. & Duprez, D. δ1-activated notch inhibits muscle differentiation without affecting Myf5 and Pax3 expression in chick limb myogenesis. Development 127, 5213-5224 (2000).
56. Houzelstein, D. et al. The homeobox gene Msx1 is expressed in a subset of somites, and in muscle progenitor cells migrating into the forelimb. Development 126, 2689-2701 (1999).
57. Bendall, A. J., Ding, J., Hu, G., Shen, M. M. & Abate-Shen, C. Msx1 antagonizes the myogenic activity of Pax3 in migrating limb muscle precursors. Development 126, 4965-4976 (1999).
58. Woloshin, P. et al. MSX1 inhibits myoD expression in fibroblast x 10T1/2 cell hybrids. Cell 82, 611-620 (1995).
59. Odelberg, S. J., Kollhoff, A. & Keating, M. T. Dedifferentiation of mammalian myotubes induced by msx1. Cell 103, 1099-1109 (2000).
60. Williams, B. A. & Ordahl, C. P. Pax-3 expression in segmental mesoderm marks early stages in myogenic cell specification. Development 120, 785-796 (1994).
61. Bober, E., Franz, T., Arnold, H. H., Gruss, P. & Tremblay, P. Pax-3 is required for the development of limb muscles: a possible role for the migration of dermomyotomal muscle progenitor cells. Development 120, 603-612 (1994).
62. Daston, G., Lamar, E., Olivier, M. & Goulding, M. Pax-3 is necessary for migration but not differentiation of limb muscle precursors in the mouse. Development 122, 1017-1027 (1996).
63. Tremblay, P. et al. A crucial role for Pax3 in the development of the hypaxial musculature and the long-range migration of muscle precursors. Dev. Biol. 203, 49-81 (1998).
64. Seale, P. et al. Pax7 is required for the specification of myogenic satellite cells. Cell 102, 777-786 (2000). This work on Pax7-deficient muscles shows that Pax7 is required for the development of the satellite-cell lineage, but not for embryonic and fetal muscle lineages.
65. Borycki, A. G., Li, J., Jin, F., Emerson, C. P. & Epstein, J. A. Pax3 functions in cell survival and in pax7 regulation. Development 126, 1665-1674 (1999).
66. Tajbakhsh, S., Rocancourt, D., Cossu, G. & Buckingham, M. Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of MyoD. Cell 89, 127-138 (1997). This important article defines a hierarchical genetic relationship whereby Pax3 and Myf5 function upstream of MyoD for embryonic body-muscle development.
67. Maroto, M. et al. Ectopic Pax-3 activates MyoD and Myf-5 expression in embryonic mesoderm and neural tissue. Cell 89, 139-48 (1997).
68. Ridgeway, A. G. & Skerjanc, I. S. Pax3 is essential for skeletal myogenesis and the expression of Six1 and Eya2. J. Biol. Chem. 276, 19033-19039 (2001).
69. Magnaghi, P., Roberts, C., Lorain, S., Lipinski, M. & Scambler, P. J. HIRA, a mammalian homologue of Saccharomyces cerevisiae transcriptional co-repressors, interacts with Pax3. Nature Genet. 20, 74-77 (1998).
70. Lagutina, I., Conway, S. J., Sublett, J. & Grosveld, G. C. Pax3-FKHR knock-in mice show developmental aberrations but do not develop tumors. Mol. Cell. Biol. 22, 7204-7216 (2002).
71. Khan, J. et al. cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. Proc. Natl Acad. Sci. USA 96, 13264-13269 (1999).
72. Ridgeway, A. G., Petropoulos, H., Wilton, S. & Skerjanc, I. S. Wnt signaling regulates the function of MyoD and myogenin. J. Biol. Chem. 275, 32398-32405 (2000).
73. Petropoulos, H. & Skerjanc, I. S. β-catenin is essential and sufficient for skeletal myogenesis in p19 cells. J. Biol. Chem. 277, 15393-15399 (2002).
74. Spitz, F. et al. Expression of myogenin during embryogenesis is controlled by Six/sine oculis homeoproteins through a conserved MEF3 binding site. Proc. Natl Acad. Sci. USA 95, 14220-14225 (1998).
75. Heanue, T. A. et al. Synergistic regulation of vertebrate muscle development by Dach2. Eya2, and Six1, homologs of genes required for Drosophila eye formation. Genes Dev. 13, 3231-3243 (1999).
76. Kardon, G., Heanue, T. A. & Tabin, C. J. Pax3 and Dach2 positive regulation in the developing somite. Dev. Dyn. 224, 350-355 (2002).
77. Laclef, C. et al. Altered myogenesis in Six1-deficient mice. Development 130, 2239-2252 (2003).
78. Bladt, F., Riethmacher, D., Isenmann, S., Aguzzi, A. & Birchmeier, C. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 376, 768-771 (1995).
79. Epstein, J. A., Shapiro, D. N., Cheng, J., Lam, P. Y. & Maas, R. L. Pax3 modulates expression of the c-Met receptor during limb muscle development. Proc. Natl Acad. Sci. USA 93, 4213-4218 (1996).
80. Mennerich, D., Schafer, K. & Braun, T. Pax-3 is necessary but not sufficient for lbx1 expression in myogenic precursor cells of the limb. Mech. Dev. 73, 147-158 (1998).
81. Mennerich, D. & Braun, T. Activation of myogenesis by the homeobox gene Lbx1 requires cell proliferation. EMBO J. 20, 7174-7183 (2001).
82. Brohmann, H., Jagla, K. & Birchmeier, C. The role of Lbx1 in migration of muscle precursor cells. Development 127, 437-445 (2000).
83. Gross, M. K. et al. Lbx1 is required for muscle precursor migration along a lateral pathway into the limb. Development 127, 413-424 (2000).
84. Schafer, K. & Braun, T. Early specification of limb muscle precursor cells by the homeobox gene Lbx1h. Nature Genet. 23, 213-216 (1999).
85. Schultz, E. Satellite cell proliferative compartments in growing skeletal muscles. Dev. Biol. 175, 84-94 (1996).
86. Bischoff, R. in Myology (eds Engel, A. G. & Franzini-Armstrong, C.) 97-118 (McGraw Hill, New York, 1994).
87. Hawke, T. J. & Garry, D. J. Myogenic satellite cells: physiology to molecular biology. J. Appl. Physiol. 91, 534-551 (2001).
88. Seale, P. & Rudnicki, M. A. in Stem Cells: A Cellular Fountain of Youth (eds Mattson, M. P. & Van Zant, G.) 177-200 (Elsevier, New York, 2002).
89. Armand, O., Boutineau, A. M., Mauger, A., Pautou, M. P. & Kieny, M. Origin of satellite cells in avian skeletal muscles. Arch. Anat. Microsc. Morphol. Exp. 72, 163-181 (1983).
90. De Angelis, L. et al. Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration. J. Cell. Biol. 147, 869-878 (1999).
91. Pardanaud, L. & Dieterien-Lievre, F. Ontogeny of the endothelial system in the avian model. Adv. Exp. Med. Biol. 416, 67-78 (2000).
92. Beauchamp, J. R. et al. Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells. J. Cell. Biol. 151, 1221-1234 (2000).
93. Smith, C. K., Janney, M. J. & Allen, R. E. Temporal expression of myogenic regulatory genes during activation, proliferation and differentiation of rat skeletal muscle satellite cells. J. Cell. Physiol. 159, 379-385 (1994).
94. Cornelison, D. D. & Wold, B. J. Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. Dev. Biol. 191, 270-283 (1997).
95. Seale, P. & Rudnicki, M. A. A new look at the origin, function, and "stem-cell" status of muscle satellite cells. Dev. Biol. 218, 115-124 (2000).
96. Megeney, L. A., Kablar, B., Garrett, K., Anderson, J. E. & Rudnicki, M. A. MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev. 10, 1173-1183 (1996).
97. -/- myogenic cells derived from adult skeletal muscle. J. Cell. Biol. 144, 631-643 (1999).
98. Yablonka-Reuveni, Z. et al. The transition from proliferation to differentiation is delayed in satellite cells from mice lacking MyoD. Dev. Biol. 210, 440-455 (1999).
99. -/-) satellite cells in single-fiber culture are differentiation defective and MRF4 deficient. Dev. Biol. 224, 122-137 (2000).
100. Kaul, A., Koster, M., Neuhaus, H. & Braun, T. Myf-5 revisited: loss of early myotome formation does not lead to a rib phenotype in homozygous Myf-5 mutant mice. Cell 102, 17-19 (2000).
101. Zhao, P. et al. Slug is a novel downstream target of MyoD. Temporal profiling in muscle regeneration. J. Biol. Chem. 277, 30091-30101 (2002).
102. Montarras, D., Undon, C., Pinset, C. & Domeyne, P. Cultured myf5 null and myoD null muscle precursor cells display distinct growth defects. Biol. Cell. 92, 565-572 (2000).
103. Bergstrom, D. A, et al. Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression. Mol. Cell. 9, 587-600 (2002). This paper examines MyoD-specific gene expression and shows how MyoD regulates the expression of groups of genes in a manner that is dependent on promoter context.
104. Asakura, A., Komaki, M. & Rudnicki, M. Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation 68, 245-253 (2001).
105. Wada, M. R., Inagawa-Ogashiwa, M., Shimizu, S., Yasumoto, S. & Hashimoto, N. Generation of different fates from multipotent muscle stem cells. Development 129, 2987-2995 (2002).
106. Conboy, I. M. & Rando, T. A. The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis. Dev. Cell 3, 397-409 (2002).
107. Shen, Q., Zhong, W., Jan, Y. N. & Temple, S. Asymmetric Numb distribution is critical for asymmetric cell division of mouse cerebral cortical stem cells and neuroblasts. Development 129, 4843-4853 (2002).
108. Rath, P. et al. Inscuteable-independent apicobasally oriented asymmetric divisions in the Drosophila embryonic CNS. EMBO Rep. 3, 660-665 (2002).
109. Dooley, C. M., James, J., Jane McGlade, C. & Ahmad, I. Involvement of numb in vertebrate retinal development: evidence for multiple roles of numb in neural differentiation and maturation. J. Neurobiol. 54, 313-325 (2003).
110. Buckingham, M. et al. The formation of skeletal muscle: from somite to limb. J. Anat. 202, 59-68 (2003).
111. Tatsumi, R., Anderson, J. E., Nevoret, C. J., Halevy, O. & Allen, R. E. HGF/SF is present in normal adult skeletal muscle and is capable of activating satellite cells. Dev. Biol. 194, 114-128 (1998).
112. Allen, R. E., Sheehan, S. M., Taylor, R. G., Kendall, T. L. & Rice, G. M. Hepatocyte growth factor activates quiescent skeletal muscle satellite cells in vitro. J. Cell. Physiol. 165, 307-312 (1995).
113. Anastasi, S. et al. A natural hepatocyte growth factor/scatter factor autocrine loop in myoblast cells and the effect of the constitutive Met kinase activation on myogenic differentiation. J. Cell. Biol. 137, 1057-1068 (1997).
114. Rudnicki, M. A. et al. MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75, 1351-1359 (1993).
115. Partridge, T. The current status of myoblast transfer. Neurol. Sci. 21, S939-S942 (2000).
116. Bittner, R. E. et al. Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat. Embryol. 199, 391-396 (1999).
117. Gussoni, E. et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401, 390-394 (1999).
118. Wakeford, S., Watt, D. J. & Partridge, T. A. X-irradiation improves mdx mouse muscle as a model of myofiber loss in DMD. Muscle Nerve 14, 42-50 (1991).
119. Pagel, C. N. & Partridge, T. A. Covert persistence of mdx mouse myopathy is revealed by acute and chronic effects of irradiation. J. Neurol. Sci. 164, 103-116 (1999).
120. Goodell, M. A., Brose, K., Paradis, G., Conner, A. S. & Mulligan, R. C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183, 1797-1806 (1996).
121. Goodell, M. A. et al. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nature Med. 3, 1337-1345 (1997).
122. Asakura, A., Seale, P., Girgis-Gabardo, A. & Rudnicki, M. A. Myogenic specification of side population cells in skeletal muscle. J. Cell. Biol. 159, 123-134 (2002).
123. Lee, J. Y. et al. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J. Cell. Biol. 150, 1085-1100 (2000).
124. Torrente, Y. et al. Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice, J. Cell. Biol. 152, 335-348 (2001).
125. Baylies, M. K. & Michelson, A. M. Invertebrate myogenesis: looking back to the future of muscle development. Curr. Opin. Genet. Dev. 11, 431-439 (2001).
126. Arbeitman, M. N. et al. Gene expression during the life cycle of Drosophila melanogaster. Science 297, 2270-2275 (2002).
127. Semsarian, C. et al. Skeletal muscle hypertrophy is mediated by a Ca2+-dependent calcineurin signalling pathway. Nature 400, 576-581 (1999).
128. Sakuma, K. et al. Calcineurin is a potent regulator for skeletal muscle regeneration by association with NFATc1 and GATA-2. Acta Neuropathol. 105, 271-280 (2003).
129. Musaro, A., McCullagh, K. J., Naya, F. J., Olson, E. N. & Rosenthal, N. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NFATc1. Nature 400, 581-585 (1999).
130. Musaro, A. et al. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nature Genet. 27, 195-200 (2001).
131. Friday, B. B. & Pavlath, G. K. A calcineurin- and NFAT-dependent pathway regulates Myf5 gene expression in skeletal muscle reserve cells. J. Cell. Sci. 114, 303-310 (2001).
132. Liu, D., Black, B. L. & Derynck, R. TGF-β inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. Genes Dev. 15, 2950-2966 (2001).
133. Cornelison, D. D., Filla, M. S., Stanley, H. M., Rapraeger, A. C. & Olwin, B. B. Syndecan-3 and syndecan-4 specifically mark skeletal muscle satellite cells and are implicated in satellite cell maintenance and muscle regeneration. Dev. Biol. 239, 79-94 (2001).